| |
| |
|
| Insider
Information: |
Reich Siegfried |
| Relationship: |
EVP & Chief Scientific... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
17,015 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,293,310 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
17,015 |
|
|
| Total
Value |
$1,293,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -100.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sgx Pharmaceuticals, Inc. |
SGXP |
VP, Drug Discovery |
2008-08-20 |
0 |
2007-01-16 |
0 |
Premium* |
|
|
Turning Point Therapeutics, Inc. |
TPTX |
EVP & Chief Scientific... |
2022-02-09 |
17,015 |
2021-02-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TPTX |
Turning Point Therapeutic... |
EVP & Chief Scientific Officer |
• – – |
2022-02-09 |
4 |
S |
$36.30 |
$14,411 |
D/D |
(397) |
3,448 |
0 |
% |
|
| TPTX |
Turning Point Therapeutic... |
EVP & Chief Scientific Officer |
• – – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
13,567 |
17,015 |
0 |
- |
|
| TPTX |
Turning Point Therapeutic... |
EVP & Chief Scientific Officer |
• – – |
2021-03-04 |
4 |
AS |
$102.01 |
$3,734,075 |
D/D |
(35,550) |
3,845 |
0 |
% |
|
| TPTX |
Turning Point Therapeutic... |
EVP & Chief Scientific Officer |
• – – |
2021-03-04 |
4 |
OE |
$51.28 |
$1,823,004 |
D/D |
35,550 |
39,395 |
0 |
- |
|
| TPTX |
Turning Point Therapeutic... |
EVP & Chief Scientific Officer |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,845 |
3,845 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-08-20 |
4 |
D |
$3.00 |
$72,669 |
D/D |
(24,223) |
0 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-08-15 |
4 |
AS |
$2.98 |
$2,327 |
D/D |
(781) |
24,223 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
25,004 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
24,223 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-07-15 |
4 |
AS |
$3.05 |
$2,383 |
D/D |
(781) |
23,442 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
23,441 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-06-16 |
4 |
AS |
$1.65 |
$1,289 |
D/D |
(781) |
22,660 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-05-15 |
4 |
AS |
$1.45 |
$1,132 |
D/D |
(781) |
21,879 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
22,660 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-04-15 |
4 |
AS |
$1.19 |
$929 |
D/D |
(781) |
21,097 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
21,878 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
21,097 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-03-17 |
4 |
AS |
$4.01 |
$3,132 |
D/D |
(781) |
20,316 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-02-15 |
4 |
AS |
$4.05 |
$3,163 |
D/D |
(781) |
19,534 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
20,315 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-01-15 |
4 |
AS |
$4.44 |
$3,468 |
D/D |
(781) |
18,753 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2008-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
19,534 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2007-12-17 |
4 |
AS |
$4.75 |
$3,710 |
D/D |
(781) |
17,971 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2007-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
18,752 |
0 |
- |
|
| SGXP |
Sgx Pharmaceuticals, Inc. |
VP, Drug Discovery |
• – – |
2007-11-15 |
4 |
AS |
$5.10 |
$3,983 |
D/D |
(781) |
17,190 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
